Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Pentosan polysulfate treatment of mucopolysaccharidosis type IIIA mice
Ningning Guo
, Victor Deangelis
, Changzhi Zhu
,
Edward H. Schuchman
,
Calogera M. Simonaro
Genetics and Genomic Sciences
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pentosan polysulfate treatment of mucopolysaccharidosis type IIIA mice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pentosan Polysulfate
100%
Mucopolysaccharidosis Type IIIA
100%
Aged Mice
33%
Cytokine Levels
22%
Once-weekly
22%
Plasma Cytokines
22%
Histological Analysis
11%
Hyperactivity
11%
Neurodegenerative Diseases
11%
Macrophage Infiltration
11%
Treatment Duration
11%
Disease Marker
11%
Intracerebroventricular Administration
11%
Learning Behavior
11%
Brain-behavior Relationships
11%
Anxiety-like Behavior
11%
Systemic Organ
11%
Photosystem II
11%
Intermediate Effect
11%
Neuropathological Findings
11%
Systemic Effects
11%
Neurobehavioral Tests
11%
Lysosomal Disease
11%
Brain Inflammation
11%
Brain Markers
11%
Systemic Analysis
11%
Sanfilippo Syndrome
11%
Neuroinflammatory Diseases
11%
Brain Neuropathology
11%
Veterinary Science and Veterinary Medicine
Mouse
100%
Pentosan Polysulfate
100%
Blood Plasma
22%
Macrophage
11%
Diseases
11%
Inflammation
11%
Neuroscience
Pentosan Polysulfate
100%
Behavior (Neuroscience)
22%
Blood Plasma
22%
Cytokine
22%
Intracerebroventricular
22%
Hyperactivity
11%
Macrophage
11%
Neurobehavioral Testing
11%
Intracerebroventricular Drug Administration
11%